openPR Logo
Press release

Paclitaxel Injection Market Revenue Growth Predicted by 2026

08-23-2017 12:49 PM CET | Health & Medicine

Press release from: Persistence Market Research

Paclitaxel Injection Market Revenue Growth Predicted by 2026

The increasing prevalence of cancer is the major driving factor for the significant growth of this market. Paclitaxel injection has better efficiency for the treatment of cancer than other medication, besides that this is also easily available in the market which is responsible for the growth of this market. Major players of paclitaxel injection market are focusing on development of more improved paclitaxel injection which will be a remarkable opportunity for this market to grow. Several adverse effects such as blood clot, allergy, leucopenia, diarrhea and weight loss can restrain the growth of paclitaxel injection market. The high cost of drug, which is less affordable in low economic countries can also hinder the growth of paclitaxel injection market.

To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/12697

Paclitaxel injection market is expected show substantial growth over the forecast period. According to World Health Organization, in 2012 around 8.2 million died due to cancer globally. Based on indication paclitaxel injection market is segmented as breast cancer, ovarian cancer, cervical cancer, prostate cancer, lungs cancer, stomach cancer and other. From all indication, breast cancer segment is expected to gain maximum share for paclitaxel injection market due to growing incidences of breast cancer. Based on the end user, paclitaxel injection market is classified as hospital, clinics, and cancer research institute. Among all end user, hospital segment is expected to gain maximum share for paclitaxel injection market.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/12697

On the basis of regional presence, global paclitaxel injection market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America is expected to dominate the paclitaxel injection market due to high prevalence of breast cancer and stomach cancer. Europe and Asia-Pacific then follow this market. Asia-Pacific region is projected to show remarkable growth for paclitaxel injection market. In Asia-Pacific, India and China are major markets due to high population. Paclitaxel injection is the second largest pharmaceutical market in China.

Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/12697


Some of the major players in paclitaxel injection market are Abbott Laboratories, Pfizer, Inc., Fresenius Kabi SE & Co. KGaA., Strides Arcolab Limited, Sagent Pharmaceuticals, Inc. Bristol-Myers Squibb Company, Celgene Corporation, Taj Accura Pharmaceuticals, Khandelwal Laboratories Pvt. Lmt., Luye Pharma Group, Youcare Pharmaceutical Group Co., Ltd. and BEIJING Union Pharmaceutical Factory.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paclitaxel Injection Market Revenue Growth Predicted by 2026 here

News-ID: 681596 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Paclitaxel

Global Paclitaxel Market Study 2015-2025, by Segment (Natural Paclitaxel, Semi-s …
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents. The global Paclitaxel
Paclitaxel HPLC Global Market Research Report 2025
Paclitaxel HPLC Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-chemical/paclitaxel-hplc-market/81094 The report firstly introduced the Paclitaxel HPLC basics: definitions, classifications, applications and market
Paclitaxel Global Market Research Report 2025
Paclitaxel Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/paclitaxel-market-3/81092 The report firstly introduced the Paclitaxel basics: definitions, classifications, applications and market overview; product
Paclitaxel Injection Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Paclitaxel Injection market. Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers. Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once
Global Paclitaxel Market Research Report 2017: Novasep, Samyang
In this report, the global Paclitaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Paclitaxel in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Fill
Paclitaxel Injection Market Snapshot by 2016 - 2026
Paclitaxel injection is a gelatinous drug, which is obtained from Pacific yew trees, after chemical synthesis process. It’s a sub-segment of antineoplastic drug class, used to cure cancer in breast, lungs, ovaries, stomach, cervix and other. Paclitaxel infection targets the tubulin, which is small globular protein in the human cell. It should be injected under the supervision of oncologist having experience in chemotherapy. It is not prescribed by the physician